CPHI [CHINA PHARMAS,] SC 13G/A: CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS

[CUSIP No. 16941T104 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OFOVE PERSONS (ENTITIES ONLY) Peter Siris 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A (SEE INSTRUCTIONS) (a)[_] (b)[X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH]

By | 2016-02-07T21:46:34+00:00 February 12th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware CPHI Nevada This Agreement and Plan of Merger (the “ WHEREAS WHEREAS WHEREAS CPHI Delaware Common Stock CPHI Delaware Preferred Stock WHEREAS CPHI Nevada Common Stock CPHI Nevada Preferred Stock WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Merger Merger Effective Time DGCL NRS 1. Principal Office of CPHI Nevada 2. Corporate Documents 3.] [ARTICLES OF INCORPORATION OF CHINA PHARMA HOLDINGS, INC. ARTICLE I The name of the corporation (which is hereinafter referred to as the "Corporation") is China Pharma Holdings, Inc. ARTICLE II The address of the registered office of the Corporation in the State of Nevada is 10 Bodie Drive, Carson City, NV 89706. The name of the registered agent of the] [BY-LAWS OF CHINA PHARMA HOLDINGS, INC. (a Nevada corporation) ARTICLE I STOCKHOLDERS Section 1. Certificates Representing Stock (a) (b) (c) Section 2. Uncertificated Shares Section 3. Fractional Share Interests Section 4. Stock Transfers Section 5. Record Date For Stockholders Section 6. Meaning of Certain Terms 2 Section 7. Stockholder Meetings (a) Time (b) Place (c) Call (d) Notice or Waiver]

By | 2016-03-03T17:26:57+00:00 January 4th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware

[AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware CPHI Nevada This Agreement and Plan of Merger (the “ WHEREAS WHEREAS WHEREAS CPHI Delaware Common Stock CPHI Delaware Preferred Stock WHEREAS CPHI Nevada Common Stock CPHI Nevada Preferred Stock WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Merger Merger Effective Time DGCL NRS 1. Principal Office of CPHI Nevada 2. Corporate Documents 3.] [ARTICLES OF INCORPORATION OF CHINA PHARMA HOLDINGS, INC. ARTICLE I The name of the corporation (which is hereinafter referred to as the "Corporation") is China Pharma Holdings, Inc. ARTICLE II The address of the registered office of the Corporation in the State of Nevada is 10 Bodie Drive, Carson City, NV 89706. The name of the registered agent of the] [BY-LAWS OF CHINA PHARMA HOLDINGS, INC. (a Nevada corporation) ARTICLE I STOCKHOLDERS Section 1. Certificates Representing Stock (a) (b) (c) Section 2. Uncertificated Shares Section 3. Fractional Share Interests Section 4. Stock Transfers Section 5. Record Date For Stockholders Section 6. Meaning of Certain Terms 2 Section 7. Stockholder Meetings (a) Time (b) Place (c) Call (d) Notice or Waiver]

By | 2016-03-03T17:28:45+00:00 January 4th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware CPHI Nevada Thisreement and Plan of Merger (the WHEREAS WHEREAS WHEREAS CPHI Delawaremmon Stock CPHI Delaware Preferred Stock WHEREAS CPHI Nevadammon Stock CPHI Nevada Preferred Stock WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Principal Office of CPHI Nevada 2.rporate Documents] [ARTICLES OFORPORATION OF CHINA PHARMAS, ARTICLE I The name of therporation (which is hereinafter referred to the "Corporation") is China Pharmas, ARTICLE II Thedress of the registered office of therporation in the State of Nevada is 10 Bodie Drive,rson City, 89706. The name of the registeredent of therporation is Unisearch,] [BY-LAWS OF CHINA PHARMAS, (a Nevadarporation) ARTICLE I STOCKHOLDERS (b) (c) Section 2. Uncertificated Shares 2 Section 7. Stockholder Meetings (a) Time (b) Place (c)ll 3 (f)nduct of Meeting 4 ARTICLE II DIRECTORS Section 1. Functions and Definition Section 2. Qualifications and Number Section 3. Term]

By | 2016-02-07T21:47:59+00:00 January 4th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware

[AGREEMENT AND PLAN OF MERGER Plan CPHI Delaware CPHI Nevada Thisreement and Plan of Merger (the WHEREAS WHEREAS WHEREAS CPHI Delawaremmon Stock CPHI Delaware Preferred Stock WHEREAS CPHI Nevadammon Stock CPHI Nevada Preferred Stock WHEREAS WHEREAS WHEREAS WHEREAS NOW, THEREFORE Principal Office of CPHI Nevada 2.rporate Documents] [ARTICLES OFORPORATION OF CHINA PHARMAS, ARTICLE I The name of therporation (which is hereinafter referred to the "Corporation") is China Pharmas, ARTICLE II Thedress of the registered office of therporation in the State of Nevada is 10 Bodie Drive,rson City, 89706. The name of the registeredent of therporation is Unisearch,] [BY-LAWS OF CHINA PHARMAS, (a Nevadarporation) ARTICLE I STOCKHOLDERS (b) (c) Section 2. Uncertificated Shares 2 Section 7. Stockholder Meetings (a) Time (b) Place (c)ll 3 (f)nduct of Meeting 4 ARTICLE II DIRECTORS Section 1. Functions and Definition Section 2. Qualifications and Number Section 3. Term]

By | 2016-02-07T21:48:34+00:00 January 4th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 21, 2012 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]

By | 2016-03-03T17:29:59+00:00 December 26th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORT Date of Report

[--------------- FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): December 21, 2012 CHINA PHARMA HOLDINGS, INC. --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) Item 5.07 Submission of Matters to a Vote of]

By | 2016-03-03T17:31:14+00:00 December 26th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): December 21, 2012 CHINA PHARMAS, --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China) Item 5.07Submission of Matters to a Vote of Security]

By | 2016-02-07T21:50:02+00:00 December 26th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-K: ————— FORM 8-K CURRENT REPORTte of Report (Date

[--------------- FORM 8-K CURRENT REPORTte of Report (Date of earliest event reported): December 21, 2012 CHINA PHARMAS, --------------------------------------- Delaware 001-34471 73-1564807 (State or other jurisdiction (Commission File No.) (IRS Employer oforporation) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China) Item 5.07Submission of Matters to a Vote of Security]

By | 2016-02-07T21:50:34+00:00 December 26th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] DEF 14A: (Original Filing)

[SCHEDULE 14A INFORMATION þ o Check the appropriate box: o Preliminary Proxy Statement o þ Definitive Proxy Statement o Definitive Additional Materials o CHINA PHARMA HOLDINGS, INC . Payment of Filing Fee (Check the appropriate box): þ No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.]

By | 2016-03-03T17:32:41+00:00 November 19th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar